Skip to main content

Cytopathology Crash Course

Tracking # 20-1085718

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

The Cytopathology Crash Course provides a high-yield review of cytopathology morphology and concepts for trainees, as well as a refresher course on core cytopathology concepts for practitioners. This online course is designed for pathology residents, cytopathology fellows, junior cytologists, practicing pathologists and cytologists; experienced pathologists seeking a review of cytopathology concepts.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

10h General (Cytology)

Clinical Laboratory Supervisor

10h General (Cytology)

Clinical Laboratory Technician

10h General (Cytology)

Clinical Laboratory Technologist

10h General (Cytology)

Public Health Director

10h General (Cytology)

Public Health Supervisor

10h General (Cytology)

Public Health Technologist

10h General (Cytology)

Disclosure statements

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

The faculty, committee members, Executive Board and staff who are in position to control the content of this activity are required to disclose to the ASC and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC has reviewed the disclosures and mitigated all relevant financial relationships.

The following individuals have reported financial relationships:

Peter B. Illei, MD: Advisor/Consultant - AstraZeneca, Sanofi/Genzyme, Consultant - Genentech, Advisior - Roche, Janssen, Merus Corp, Speaker - Eli Lilly, Sponsored research - Erbe Medical Systems, Advisor/Sponsored research - Bristol Myers Squib

Vickie Jo, MD: Stock - Merck and Co

Oscar Lin, MD, PhD: Consultant – Hologic and Jansen

Liron Pantanowitz, MD: Consultant – Hamamatsu, Advisory Board for Ibex

Martha B Pitman, MD, FIAC: Consultant – Adenocyte, LLC

Donna K. Russell, Med, CT(ASCP), HT(ASCP): Advisory Board – Hologic Scientific

Christopher J. VandenBussche, MD, PhD: Advisory board Member – AlxMED

The following individuals have reported no relevant financial relationships:

Susan A. Alperstein, MS, CT(ASCP), Kristen A. Atkins, MD, Christine N. Booth, MD, Barbara A. Centeno, MD, Deborah J. Chute, MD, Amy C. Clayton, MD, Jacqueline M. Cuda, BS, SCT(ASCP), Sean A. McNair, MPH, CT(ASCP), Michelle D. Reid, MD, Sinchita Roy-Chowdhuri, MD, PhD, Momin T. Siddiqui, MD, FIAC, Michael J. Thrall, MD, Christopher J. O’Conor, MD, PhD, Seyedreza Mousavi, MD, MS, CT(ASCP), Chelsea Peeler, MCP, HTL(ASCP)CM, CTCM, Kaitlin Sundling, MD, PhD, Bonnie Choy, MD, Sara Zadeh, MD, Michiya Nishino, MD, PhD, Kelly Ernst, MD, M. Katayoon Rezaei, MD, Rebecca Yoda, MD, M. Lisa Zhang, MD, Frida Rosenblum, MD, Nadja Falk, MD, Sigfred Lajara, MD, Ayesha Baig, MD, MSc, FRCPC, Vanda F. Torous, MD, Jimmie Stewart, MD

The ASC staff associated with the development of content for this activity reported no relevant financial relationships.